Clearpoint Neuro Inc (CLPT) - Total Liabilities
Based on the latest financial reports, Clearpoint Neuro Inc (CLPT) has total liabilities worth $74.58 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Clearpoint Neuro Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how Clearpoint Neuro Inc's total liabilities have evolved over time, based on quarterly financial data. See Clearpoint Neuro Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Clearpoint Neuro Inc Competitors by Total Liabilities
The table below lists competitors of Clearpoint Neuro Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
West Bancorporation
NASDAQ:WTBA
|
USA | $3.74 Billion |
|
Aydem Yenilenebilir Enerji AS
IS:AYDEM
|
Turkey | TL31.75 Billion |
|
Thonburi Healthcare Grp Pcl
BK:THG
|
Thailand | ฿5.92 Billion |
|
Djurslands Bank
CO:DJUR
|
Denmark | Dkr15.06 Billion |
|
Panoro Energy ASA
F:1PZ
|
Germany | €451.14 Million |
|
CNlight Co Ltd
SHE:002076
|
China | CN¥617.28 Million |
|
Shenyang Brilliant Elevator Group Co Ltd
SHE:002689
|
China | CN¥656.17 Million |
|
Bajaj Electricals Limited
NSE:BAJAJELEC
|
India | Rs22.06 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Clearpoint Neuro Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CLPT stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.96 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Clearpoint Neuro Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Clearpoint Neuro Inc (2011–2025)
The table below shows the annual total liabilities of Clearpoint Neuro Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $69.73 Million | +405.27% |
| 2024-12-31 | $13.80 Million | -35.78% |
| 2023-12-31 | $21.49 Million | +15.51% |
| 2022-12-31 | $18.60 Million | +10.77% |
| 2021-12-31 | $16.79 Million | -38.12% |
| 2020-12-31 | $27.14 Million | +269.72% |
| 2019-12-31 | $7.34 Million | +15.68% |
| 2018-12-31 | $6.35 Million | -21.35% |
| 2017-12-31 | $8.07 Million | -1.08% |
| 2016-12-31 | $8.16 Million | -32.50% |
| 2015-12-31 | $12.08 Million | -10.40% |
| 2014-12-31 | $13.49 Million | -8.30% |
| 2013-12-31 | $14.71 Million | +30.28% |
| 2012-12-31 | $11.29 Million | -54.62% |
| 2011-12-31 | $24.87 Million | -- |
About Clearpoint Neuro Inc
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which … Read more